US Broker Ratings

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring 15.62% Potential Upside for Investors

GE HealthCare Technologies Inc. (NYSE: GEHC) is an intriguing proposition for investors seeking exposure in the medical devices sector. With a market capitalization of $36.76 billion, this Chicago-based healthcare giant..

Glaukos Corporation (GKOS) Stock Analysis: A Deep Dive into Growth Potential Despite Current Challenges

As Glaukos Corporation (NYSE: GKOS) continues to carve its niche in the healthcare sector, specifically within the medical devices industry, the company presents a mix of promising growth figures and..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Analyst Ratings Indicate 51% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC), a notable player in the healthcare sector, specializes in the development and commercialization of advanced medical devices aimed at cardiac monitoring. With a market capitalization..

Bausch + Lomb (BLCO) Stock Analysis: Eyeing Growth in Healthcare with a 3.15% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO) might not be a household name for many investors, but its robust presence in the eye health sector makes it a compelling consideration for..

Summit Therapeutics Inc. (SMMT): Potential 118% Upside Amid Promising Biotech Breakthroughs

Summit Therapeutics Inc. (NASDAQ: SMMT) has emerged as a fascinating prospect for investors in the biotechnology sector, with a potential upside of 118.85% based on current analyst ratings. This promising..

Chemed Corp (CHE) Stock Analysis: Exploring a 24% Potential Upside in the Healthcare Sector

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, stands out in the medical care facilities industry for its unique dual business model. With a market cap of..

Royalty Pharma plc (RPRX) Stock Analysis: A 9% Upside Potential with Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector with its unique business model of acquiring biopharmaceutical royalties and funding innovation across various therapeutic areas. With a market..

Merit Medical Systems, Inc. (MMSI): Exploring a 26.39% Potential Upside with Strong Buy Ratings

Investors eyeing opportunities in the healthcare sector may find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing prospect. With a market capitalization of $4.89 billion, this American company is a..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a 22.44% Potential Upside in the Biotech Sector

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector with its focus on developing targeted therapies for RAS-addicted cancers. The company, founded in 2014 and headquartered in..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Analyzing a Potential 39% Upside in Biotech

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing the attention of investors with the promise of significant growth within the biotechnology sector. With a market capitalization of $10.85 billion, Madrigal is..

Exact Sciences Corporation (EXAS) Stock Analysis: A 2.55% Upside in a Booming Healthcare Sector

Exact Sciences Corporation (NASDAQ: EXAS) is commanding attention in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $19.6 billion, this innovative company has..

argenx SE (ARGX) Stock Analysis: Exploring a 27.65% Potential Upside in the Biotech Sector

argenx SE (NASDAQ: ARGX) stands as a formidable player in the biotechnology industry, particularly within the realm of autoimmune disease therapies. With a market capitalization of $50.22 billion, this Netherlands-based..

Vaxcyte, Inc. (PCVX)

⚠️ No article content returned.

..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unveiling a 37.11% Potential Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a leading player in the biotechnology sector, is drawing significant interest from investors, evidenced by a substantial market capitalization of $13.04 billion. The company, headquartered..

ADMA Biologics Inc (ADMA) Stock Analysis: Attractive 56.22% Upside Potential for Investors

ADMA Biologics Inc (NASDAQ: ADMA) is capturing investor attention with a remarkable potential upside of 56.22%, according to analyst ratings. This biopharmaceutical company, based in Ramsey, New Jersey, is making..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Medical Device Landscape with Strategic Growth

Integer Holdings Corporation (NYSE: ITGR) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.03 billion, Integer operates on..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Assessing a Potential 9.97% Upside in the Biotechnology Sector

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a stalwart in the biotechnology industry, has positioned itself as a critical player in the healthcare sector with its diverse portfolio of groundbreaking treatments and..

Telix Pharmaceuticals Limited (TLX): Investor Outlook Highlights 206% Upside Potential

Telix Pharmaceuticals Limited (TLX), an emerging titan in the healthcare sector, is captivating investor attention with its promising pipeline and a striking potential upside of 206.21%. As a commercial-stage biopharmaceutical..

Henry Schein, Inc. (HSIC) Stock Analysis: Evaluating Its Unique Position in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a robust market capitalization of $9.67 billion, the company..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unpacking a 15% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the healthcare sector, is drawing significant attention from investors with its promising 15.42% potential upside. Specializing in medical devices, Bio-Rad is..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds